Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 in persistent asthma
NCT01130064Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2010
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of dectrekumab in asthma, sponsored by Novartis. Started May 2010; status: completed.
02
Drugs
dectrekumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01130064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01130064.